Your browser doesn't support javascript.
loading
Gene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic Leukemia.
Edwards, Holly; Rubenstein, Mara; Dombkowski, Alan A; Caldwell, J Timothy; Chu, Roland; Xavier, Ana C; Thummel, Ryan; Neely, Melody; Matherly, Larry H; Ge, Yubin; Taub, Jeffrey W.
Afiliación
  • Edwards H; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, United States of America.
  • Rubenstein M; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, United States of America.
  • Dombkowski AA; Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, MI, United States of America.
  • Caldwell JT; Division of Clinical Pharmacology and Toxicology, Children's Hospital of Michigan, Detroit, Michigan, United States of America.
  • Chu R; Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI, United States of America.
  • Xavier AC; MD/PhD Program, Wayne State University School of Medicine, Detroit, MI, United States of America.
  • Thummel R; Cancer Biology Program, Wayne State University School of Medicine, Detroit, MI, United States of America.
  • Neely M; Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, MI, United States of America.
  • Matherly LH; Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI, United States of America.
  • Ge Y; Division of Pediatric Hematology/Oncology, Children's Hospital of Alabama, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Taub JW; Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI, United States of America.
PLoS One ; 11(8): e0161539, 2016.
Article en En | MEDLINE | ID: mdl-27536776
ABSTRACT
In this study we sought to identify genetic factors associated with the presenting white blood cell (WBC) count in B-precursor acute lymphoblastic leukemia (BP-ALL). Using ETV6-RUNX1-positive BP-ALL patient samples, a homogeneous subtype, we identified 16 differentially expressed genes based on the presenting WBC count (< 50,000/cumm vs > 50,000). We further confirmed that IL1R1, BCAR3, KCNH2, PIR, and ZDHHC23 were differentially expressed in a larger cohort of ETV6-RUNX1-negative BP-ALL patient samples. Statistical analysis demonstrated that expression levels of these genes could accurately categorize high and low WBC count subjects using two independent patient sets, representing positive and negative ETV6-RUNX1 cases. Further studies in leukemia cell line models will better delineate the role of these genes in regulating the white blood cell count and potentially identify new therapeutic targets.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Recuento de Leucocitos Tipo de estudio: Prognostic_studies Límite: Child / Child, preschool / Female / Humans / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Recuento de Leucocitos Tipo de estudio: Prognostic_studies Límite: Child / Child, preschool / Female / Humans / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos